Literature DB >> 21915739

Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia.

H Lahlaoui1, L Poirel, F Barguellil, M B Moussa, P Nordmann.   

Abstract

Two carbapenem-resistant Klebsiella pneumoniae isolates producing the plasmid-encoded carbapenem-hydrolyzing OXA-48 were identified. These isolates, recovered from two patients hospitalized in two different hospitals in Tunisia in December 2010, were not clonally related. Molecular investigations showed that both isolates co-produced the narrow-spectrum β-lactamases TEM-1 and SHV-1, together with the extended-spectrum β-lactamase CTX--15.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21915739     DOI: 10.1007/s10096-011-1389-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia.

Authors:  Gaelle Cuzon; Thierry Naas; Aude Lesenne; Michel Benhamou; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2010-03-30       Impact factor: 5.283

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Spread of OXA-48-encoding plasmid in Turkey and beyond.

Authors:  Amélie Carrër; Laurent Poirel; Mesut Yilmaz; Ozay Arikan Akan; Cilli Feriha; Gaëlle Cuzon; Ghassan Matar; Patrick Honderlick; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

4.  Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

Authors:  Amélie Carrër; Laurent Poirel; Haluk Eraksoy; A Atahan Cagatay; Selim Badur; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

5.  Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France.

Authors:  Laurent Poirel; Alain Ros; Amélie Carrër; Nicolas Fortineau; Anne Carricajo; Philippe Berthelot; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2011-02-03       Impact factor: 5.790

6.  Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital.

Authors:  Sonia Ktari; Basma Mnif; Fadoua Louati; Sonia Rekik; Sonda Mezghani; Fouzia Mahjoubi; Adnane Hammami
Journal:  J Antimicrob Chemother       Date:  2011-05-11       Impact factor: 5.790

7.  First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain.

Authors:  Cristina Pitart; Mar Solé; Ignasi Roca; Anna Fàbrega; Jordi Vila; Francesc Marco
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

Review 8.  Carbapenemases: molecular diversity and clinical consequences.

Authors:  Laurent Poirel; Johann D Pitout; Patrice Nordmann
Journal:  Future Microbiol       Date:  2007-10       Impact factor: 3.165

9.  VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.

Authors:  Jose-Manuel Rodriguez-Martinez; Patrice Nordmann; Nicolas Fortineau; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

Review 10.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more
  11 in total

Review 1.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

2.  Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.

Authors:  Lotfi Loucif; Ahmed Kassah-Laouar; Mahdia Saidi; Amina Messala; Widad Chelaghma; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 3.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

4.  First Report of KPC-2 and KPC-3-Producing Enterobacteriaceae in Wild Birds in Africa.

Authors:  Houssem Ben Yahia; Sarra Chairat; Haythem Gharsa; Carla Andrea Alonso; Rym Ben Sallem; Nerea Porres-Osante; Nabil Hamdi; Carmen Torres; Karim Ben Slama
Journal:  Microb Ecol       Date:  2019-05-05       Impact factor: 4.552

Review 5.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

6.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 7.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 8.  ESBL-producing Enterobacteriaceae in Africa - a non-systematic literature review of research published 2008-2012.

Authors:  Viktor Storberg
Journal:  Infect Ecol Epidemiol       Date:  2014-03-13

Review 9.  Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge.

Authors:  Olfa Dziri; Raoudha Dziri; Allaaeddin Ali El Salabi; Chedly Chouchani
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

Review 10.  A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options.

Authors:  Ann A Elshamy; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.